Bernzott U.S. Small Cap Value Fund HALO Holdings History
Bernzott U.S. Small Cap Value Fund's Halozyme Therapeutics Inc Holding Summary
As of 2024-02-29, Investment Managers Series Trust held 46,360.00 shares of Halozyme Therapeutics Inc(HALO), totaling $1.85 Mil. This investment constitutes 5.39% of their stock portfolio, and Investment Managers Series Trust now holds 0.04% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2022Q2. And since then Bernzott U.S. Small Cap Value Fund has made 3 purchases of HALO, at an average price of $41.46, for a total of 90,395.00 shares. In addition, there have been 5 sales at an average price of $39.50 for 44,035.00 shares. Based on historical transaction data and HALO's current price of $56.45, Bernzott U.S. Small Cap Value Fund's estimated gain on his HALO holdings is $609,023.65, reflecting a 16.25% gain to date.
Bernzott U.S. Small Cap Value Fund HALO ($56.45) Holding Chart
Bernzott U.S. Small Cap Value Fund HALO ($56.45) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
